Free Trial

Driehaus Capital Management LLC Increases Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Driehaus Capital Management LLC boosted its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 351,881 shares of the company's stock after buying an additional 12,464 shares during the period. Driehaus Capital Management LLC owned approximately 0.13% of Ryan Specialty worth $22,577,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. CoreCap Advisors LLC increased its stake in Ryan Specialty by 344,990.9% during the fourth quarter. CoreCap Advisors LLC now owns 37,960 shares of the company's stock worth $2,436,000 after purchasing an additional 37,949 shares during the period. Captrust Financial Advisors increased its stake in Ryan Specialty by 60.3% during the fourth quarter. Captrust Financial Advisors now owns 15,078 shares of the company's stock worth $967,000 after purchasing an additional 5,673 shares during the period. Bank of America Corp DE increased its stake in Ryan Specialty by 37.5% during the fourth quarter. Bank of America Corp DE now owns 729,606 shares of the company's stock worth $46,812,000 after purchasing an additional 199,131 shares during the period. BNP Paribas Financial Markets purchased a new stake in Ryan Specialty during the fourth quarter worth about $3,988,000. Finally, Aptus Capital Advisors LLC purchased a new stake in Ryan Specialty during the fourth quarter worth about $334,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Wells Fargo & Company cut their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada cut their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and upped their target price for the stock from $74.00 to $81.00 in a research note on Tuesday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $76.42.

Check Out Our Latest Report on Ryan Specialty

Ryan Specialty Stock Down 1.4%

RYAN traded down $0.99 on Tuesday, reaching $68.14. The company's stock had a trading volume of 670,699 shares, compared to its average volume of 974,492. The stock has a 50 day moving average of $70.13 and a two-hundred day moving average of $68.73. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market capitalization of $17.85 billion, a price-to-earnings ratio of 98.76, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.35 earnings per share. As a group, analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's payout ratio is currently 141.18%.

Insider Activity

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines